Clinical Study

Exercise Improves Immune Function, Antidepressive Response, and Sleep Quality in Patients with Chronic Primary Insomnia

Table 2

Polysomnography variables on the baseline and after exercise.

VariableBaseline
()
After exercise
()

TST (hours)5.7 ± 0.86.1 ± 0.5.02
*SOL (min)22.5 ± 238.6 ± 8<.001
LREM (min)100.4 ± 3876.0 ± 43.01
SE (%)82.2 ± 1088.9 ± 8.006
*WASO (min)53.2 ± 4938.2 ± 25.03
Arousals (events/hour)17.8 ± 2315.6 ± 13ns
Stage 1 (%)3.9 ± 23.9 ± 3ns
*Stage 2 (%)56.7 ± 754.5 ± 8ns
Stage 3 (%)4.6 ± 25.1 ± 2ns
Stage 4 (%)15.3 ± 514.5 ± 6ns
REM sleep (%)19.4 ± 621.9 ± 6.04
*Latency of Stage 1 (min)80.6 ± 8938. 9 ± 77ns
*Latency of Stage 2 (min)23.6 ± 2310.5 ± 11.01
*Latency of Stages 3 and 4 (min)55.6 ± 5133.7 ± 18.04
*AHI (events/hour)9.7 ± 98.1 ± 9ns
*PLM (events/hour)2.0 ± 42.2 ± 5ns

Paired Student’s -test or *Wilcoxon matched pairs test, significant results, ; data are expressed as mean ± SD. TST: total sleep time; SE: sleep efficiency; SOL: sleep onset latency; REM: rapid eye movements; LREM: REM sleep latency; TWT: total wake time; WASO: wake time after sleep onset; AHI: apnea hypopnea index; PLM: periodic leg movements.